Scholtz & Company, LLC Vericel Corp Transaction History
Scholtz & Company, LLC
- $203 Million
- Q4 2024
A detailed history of Scholtz & Company, LLC transactions in Vericel Corp stock. As of the latest transaction made, Scholtz & Company, LLC holds 47,660 shares of VCEL stock, worth $2.48 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
47,660
Previous 43,098
10.59%
Holding current value
$2.48 Million
Previous $1.82 Million
43.79%
% of portfolio
1.29%
Previous 0.88%
Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$419 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$181 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$168 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$125 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$116 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.45B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...